In last trading session, Compass Pathways Plc ADR (NASDAQ:CMPS) saw 1.41 million shares changing hands with its beta currently measuring 2.28. Company’s recent per share price level of $4.17 trading at $0.08 or 1.96% at ring of the bell on the day assigns it a market valuation of $285.31M. That closing price of CMPS’s stock is at a discount of -205.76% from its 52-week high price of $12.75 and is indicating a premium of 24.22% from its 52-week low price of $3.16. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.12 million shares which gives us an average trading volume of 1.14 million if we extend that period to 3-months.
For Compass Pathways Plc ADR (CMPS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Compass Pathways Plc ADR (NASDAQ:CMPS) trade information
Upright in the green during last session for gaining 1.96%, in the last five days CMPS remained trading in the green while hitting it’s week-highest on Thursday, 01/30/25 when the stock touched $4.17 price level, adding 4.79% to its value on the day. Compass Pathways Plc ADR’s shares saw a change of 10.32% in year-to-date performance and have moved 7.75% in past 5-day. Compass Pathways Plc ADR (NASDAQ:CMPS) showed a performance of 4.51% in past 30-days. Number of shares sold short was 4.31 million shares which calculate 3.98 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 23 to the stock, which implies a rise of 81.87% to its current value. Analysts have been projecting 23 as a low price target for the stock while placing it at a high target of 23. It follows that stock’s current price would drop -451.56% in reaching the projected high whereas dropping to the targeted low would mean a loss of -451.56% for stock’s current value.
Compass Pathways Plc ADR (CMPS) estimates and forecasts
Statistics highlight that Compass Pathways Plc ADR is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -45.20% of value to its shares in past 6 months, showing an annual growth rate of -0.43% while that of industry is 6.70. Apart from that, the company came lowering its revenue forecast for fiscal year 2025.
In 2025, company’s earnings growth rate is likely to be around -2.00% while estimates for its earnings growth in next 5 years are of 8.88%.
Compass Pathways Plc ADR (NASDAQ:CMPS)’s Major holders
Insiders are in possession of 16.40% of company’s total shares while institution are holding 45.45 percent of that, with stock having share float percentage of 54.36%. Investors also watch the number of corporate investors in a company very closely, which is 45.45% institutions for Compass Pathways Plc ADR that are currently holding shares of the company. TCG CROSSOVER MANAGEMENT, LLC is the top institutional holder at CMPS for having 3.86 million shares of worth $23.3 million. And as of 2024-06-30, it was holding 6.0073 of the company’s outstanding shares.
The second largest institutional holder is CITADEL ADVISORS LLC, which was holding about 3.67 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.7118 of outstanding shares, having a total worth of $22.16 million.
On the other hand, ARK ETF Tr-ARK Genomic Revolution ETF and iShares Biotechnology ETF are the top two Mutual Funds which own company’s shares. As of Nov 30, 2024 , the former fund manager was holding 1.87 shares of worth $7.79 million or 2.73% of the total outstanding shares. The later fund manager was in possession of 360.99 shares on Nov 30, 2024 , making its stake of worth around $1.51 million in the company or a holder of 0.53% of company’s stock.